Eliminationen af iloprost reduceres hos patienter med hepatisk dysfunktion og hos patienter med dialysekrævende nyreinsufficiens (se pkt.
Iloprost elimination is reduced in patients with hepatic dysfunction and in patients with renal failure requiring dialysis (see section 5.2).